Comparative assessment of the quadriceps and the diaphragm in patients with COPD.
暂无分享,去创建一个
F. Maltais | P. Dekhuijzen | R. Debigaré | M. Caron | Dekhuijzen Pn | Caron Ma | Debigaré R | Maltais F
[1] T. Clanton,et al. Respiratory muscle fiber remodeling in chronic hyperinflation: dysfunction or adaptation? , 2009, Journal of applied physiology.
[2] S. Hussain,et al. Oxidised proteins and superoxide anion production in the diaphragm of severe COPD patients , 2009, European Respiratory Journal.
[3] A. Agustí,et al. Abnormal mitochondrial function in locomotor and respiratory muscles of COPD patients , 2009, European Respiratory Journal.
[4] N. Hopkinson,et al. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. A statement of the American Thoracic Society and European Respiratory Society. , 2009, American journal of respiratory and critical care medicine.
[5] J. Bourbeau,et al. The mitochondrial phenotype of peripheral muscle in chronic obstructive pulmonary disease: disuse or dysfunction? , 2008, American journal of respiratory and critical care medicine.
[6] J. Barberà,et al. Chronic endurance exercise induces quadriceps nitrosative stress in patients with severe COPD , 2008, Thorax.
[7] L. Grimelius,et al. Overexpression of von Hippel-Lindau protein in skeletal muscles of patients with chronic obstructive pulmonary disease , 2008, Journal of Clinical Pathology.
[8] K. Webb,et al. Organization of metabolic pathways in vastus lateralis of patients with chronic obstructive pulmonary disease. , 2008, American journal of physiology. Regulatory, integrative and comparative physiology.
[9] T. Duhamel,et al. Abnormal sarcoplasmic reticulum Ca2+-sequestering properties in skeletal muscle in chronic obstructive pulmonary disease. , 2008, American journal of physiology. Cell physiology.
[10] D. Gerrard,et al. Modulation of skeletal muscle fiber type by mitogen‐activated protein kinase signaling , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[11] Amy E. Knapp,et al. Skeletal muscle capillarity during hypoxia: VEGF and its activation. , 2008, High altitude medicine & biology.
[12] Marco Sandri,et al. Signaling in muscle atrophy and hypertrophy. , 2008, Physiology.
[13] M. Polkey,et al. Physiological properties of human diaphragm muscle fibres and the effect of chronic obstructive pulmonary disease , 2008, The Journal of physiology.
[14] E. Barreiro,et al. Activación de células satélite en el músculo intercostal de pacientes con EPOC , 2008 .
[15] A. Brunet,et al. The FoxO code , 2008, Oncogene.
[16] P. Wagner,et al. Possible mechanisms underlying the development of cachexia in COPD , 2008, European Respiratory Journal.
[17] Jeong-Ho Kim,et al. Forkhead box protein O1 negatively regulates skeletal myocyte differentiation through degradation of mammalian target of rapamycin pathway components. , 2008, Endocrinology.
[18] C. Ottenheijm,et al. Diaphragm adaptations in patients with COPD , 2008, Respiratory research.
[19] F. Maltais,et al. Profiling of mRNA Expression in Quadriceps of Patients with COPD and Muscle Wasting , 2008, COPD.
[20] M. Polkey,et al. Cytokine profile in quadriceps muscles of patients with severe COPD , 2007, Thorax.
[21] A. Russell,et al. Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease. , 2007, American journal of respiratory and critical care medicine.
[22] P. Schrauwen,et al. Peroxisome proliferator-activated receptor expression is reduced in skeletal muscle in COPD , 2007, European Respiratory Journal.
[23] M. Hesselink,et al. Reduced mitochondrial density in the vastus lateralis muscle of patients with COPD , 2007, European Respiratory Journal.
[24] C. Ottenheijm,et al. Diaphragm muscle fiber dysfunction in chronic obstructive pulmonary disease: toward a pathophysiological concept. , 2007, American journal of respiratory and critical care medicine.
[25] S. Zakynthinos,et al. Effects of rehabilitative exercise on peripheral muscle TNF&agr;, IL-6, IGF-I and MyoD expression in patients with COPD , 2007, Thorax.
[26] Maurice P Zeegers,et al. Muscle fibre type shifting in the vastus lateralis of patients with COPD is associated with disease severity: a systematic review and meta-analysis , 2007, Thorax.
[27] Bingwen Jin,et al. Activation of the ubiquitin-proteasome pathway in the diaphragm in chronic obstructive pulmonary disease. , 2006, American journal of respiratory and critical care medicine.
[28] R. Rodenburg,et al. Metabolic capacity of the diaphragm in patients with COPD. , 2006, Respiratory medicine.
[29] J. Viña,et al. Oxidative and nitrosative stress in the diaphragm of patients with COPD , 2006, International journal of chronic obstructive pulmonary disease.
[30] E. Wouters,et al. COPD as a multicomponent disease: inventory of dyspnoea, underweight, obesity and fat free mass depletion in primary care. , 2006, Primary care respiratory journal : journal of the General Practice Airways Group.
[31] C. Ottenheijm,et al. Titin and diaphragm dysfunction in chronic obstructive pulmonary disease. , 2006, American journal of respiratory and critical care medicine.
[32] W. Reid,et al. Increased injury and intramuscular collagen of the diaphragm in COPD: autopsy observations , 2006, European Respiratory Journal.
[33] C. Ottenheijm,et al. Diaphragm dysfunction in chronic obstructive pulmonary disease. , 2005, American journal of respiratory and critical care medicine.
[34] E. Wouters,et al. Body composition and mortality in chronic obstructive pulmonary disease. , 2005, The American journal of clinical nutrition.
[35] S. Hussain,et al. Oxidative stress and respiratory muscle dysfunction in severe chronic obstructive pulmonary disease. , 2005, American journal of respiratory and critical care medicine.
[36] F. Maltais,et al. Adaptation of the diaphragm and the vastus lateralis in mild-to-moderate COPD , 2004, European Respiratory Journal.
[37] R. Casaburi,et al. Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease. , 2004, American journal of respiratory and critical care medicine.
[38] Hiroyuki Aburatani,et al. Skeletal Muscle FOXO1 (FKHR) Transgenic Mice Have Less Skeletal Muscle Mass, Down-regulated Type I (Slow Twitch/Red Muscle) Fiber Genes, and Impaired Glycemic Control*[boxs] , 2004, Journal of Biological Chemistry.
[39] Naftali Kaminski,et al. Effects of exercise training on quadriceps muscle gene expression in chronic obstructive pulmonary disease. , 2004, Journal of applied physiology.
[40] G. Yancopoulos,et al. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. , 2004, Molecular cell.
[41] Marco Sandri,et al. Foxo Transcription Factors Induce the Atrophy-Related Ubiquitin Ligase Atrogin-1 and Cause Skeletal Muscle Atrophy , 2004, Cell.
[42] A. Goldberg,et al. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[43] M. Orozco-Levi. Structure and function of the respiratory muscles in patients with COPD: impairment or adaptation? , 2003, European Respiratory Journal.
[44] M. Decramer,et al. CHRONIC OBSTRUCTIVE PULMONARY DISEASE Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I , 2003 .
[45] E. Wouters,et al. Myopathological features in skeletal muscle of patients with chronic obstructive pulmonary disease , 2003, European Respiratory Journal.
[46] P. Hasselgren,et al. Sepsis upregulates the gene expression of multiple ubiquitin ligases in skeletal muscle. , 2003, The international journal of biochemistry & cell biology.
[47] X. Bigard,et al. Mitochondrial electron transport chain function is enhanced in inspiratory muscles of patients with chronic obstructive pulmonary disease. , 2003, American journal of respiratory and critical care medicine.
[48] F. Maltais,et al. In vitro and in vivo contractile properties of the vastus lateralis muscle in males with COPD , 2003, European Respiratory Journal.
[49] J. Gea,et al. COPD and body weight in a Mediterranean population. , 2002, Clinical nutrition.
[50] Y. Lacasse,et al. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. , 2002, American journal of respiratory and critical care medicine.
[51] G. Kwakkel,et al. Effects of controlled inspiratory muscle training in patients with COPD: a meta-analysis , 2002, European Respiratory Journal.
[52] X. Busquets,et al. Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease. , 2002, American journal of respiratory and critical care medicine.
[53] Jiandie D. Lin,et al. Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres , 2002, Nature.
[54] Maria Cristina C Gomes-Marcondes,et al. Induction of protein catabolism and the ubiquitin-proteasome pathway by mild oxidative stress. , 2002, Cancer letters.
[55] H. van Mameren,et al. Skeletal muscle fibre-type shifting and metabolic profile in patients with chronic obstructive pulmonary disease , 2002, European Respiratory Journal.
[56] C. Gregory,et al. Bioenergetic adaptation of individual human diaphragmatic myofibers to severe COPD. , 2002, Journal of applied physiology.
[57] A. Goldberg,et al. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[58] J. Gea,et al. Injury of the human diaphragm associated with exertion and chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.
[59] G. Yancopoulos,et al. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo , 2001, Nature Cell Biology.
[60] D J Glass,et al. Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy , 2001, Science.
[61] J. Barberà,et al. Reduced muscle redox capacity after endurance training in patients with chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.
[62] E. Bozkanat,et al. Skeletal muscle dysfunction in chronic obstructive pulmonary disease , 2001, Respiratory research.
[63] J. Gea,et al. Metabolic characteristics of the deltoid muscle in patients with chronic obstructive pulmonary disease. , 2001, The European respiratory journal.
[64] F. Maltais,et al. Oxidative enzyme activities of the vastus lateralis muscle and the functional status in patients with COPD , 2000, Thorax.
[65] A. Goris,et al. Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease. , 2000, Respiratory medicine.
[66] M. Decramer,et al. Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives. , 2000, The American journal of clinical nutrition.
[67] J. Shrager,et al. Developmental myosin heavy chains in the adult human diaphragm: coexpression patterns and effect of COPD. , 2000, Journal of applied physiology.
[68] C. Wykoff,et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis , 1999, Nature.
[69] J. Gea,et al. Subcellular adaptation of the human diaphragm in chronic obstructive pulmonary disease. , 1999, The European respiratory journal.
[70] F. Maltais,et al. Chronic obstructive pulmonary disease: capillarity and fiber-type characteristics of skeletal muscle. , 1998, Journal of cardiopulmonary rehabilitation.
[71] L. Kaiser,et al. Cellular Adaptations in the Diaphragm in Chronic Obstructive Pulmonary Disease , 1998 .
[72] F. Maltais,et al. Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. , 1998, Medicine and science in sports and exercise.
[73] W. Zhu,et al. A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type. , 1998, Genes & development.
[74] F. Maltais,et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.
[75] I. Harting,et al. Cytochrome oxidase activity and mitochondrial gene expression in skeletal muscle of patients with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.
[76] M. Tisdale. Biology of cachexia. , 1997, Journal of the National Cancer Institute.
[77] Se-Jin Lee,et al. Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member , 1997, nature.
[78] M. Buck,et al. Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants. , 1996, The EMBO journal.
[79] P. Macklem,et al. Nutritional status and mortality in chronic obstructive pulmonary disease. , 1996, American journal of respiratory and critical care medicine.
[80] N. Jones,et al. Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders. , 1995, American journal of respiratory and critical care medicine.
[81] E. Wouters,et al. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. , 1993, The American review of respiratory disease.
[82] P. Macklem,et al. Contractile properties of the human diaphragm during chronic hyperinflation. , 1991, The New England journal of medicine.
[83] A. Grassino,et al. Inspiratory muscle dysfunction and chronic hypercapnia in chronic obstructive pulmonary disease. , 1991, The American review of respiratory disease.
[84] D. F. Rochester,et al. COPD and human diaphragm muscle dimensions. , 1987, Chest.
[85] H. Hoppeler,et al. Influences of endurance training on the ultrastructural composition of the different muscle fiber types in humans , 1985, Pflügers Archiv.
[86] C. Roussos,et al. Diaphragm in emphysematous hamsters: sarcomere adaptability. , 1983, Journal of applied physiology: respiratory, environmental and exercise physiology.
[87] L. Larsson. Histochemical characteristics of human skeletal muscle during aging. , 1983, Acta physiologica Scandinavica.
[88] L. Heunks,et al. Levosimendan enhances force generation of diaphragm muscle from patients with chronic obstructive pulmonary disease. , 2009, American journal of respiratory and critical care medicine.
[89] E. Barreiro,et al. [Activation of satellite cells in the intercostal muscles of patients with chronic obstructive pulmonary disease]. , 2008, Archivos de bronconeumologia.
[90] B. Nordestgaard,et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. , 2006, American journal of respiratory and critical care medicine.
[91] A. McArdle,et al. Skeletal Muscle Damage with Exercise and Aging , 2005, Sports medicine.
[92] W. Mitch,et al. Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions. , 2004, The Journal of clinical investigation.
[93] Marc S. Williams. Myostatin mutation associated with gross muscle hypertrophy in a child. , 2004, The New England journal of medicine.
[94] Jiandie D. Lin,et al. Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. , 2002, Nature.
[95] A. Goldberg,et al. Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states. , 1999, The Journal of nutrition.
[96] F. Maltais,et al. Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD. , 1996, American journal of respiratory and critical care medicine.
[97] B. Burrows. The bronchial and emphysematous types of chronic obstructive lung disease in London and Chicago. , 1968, Aspen Emphysema Conference.